SHARE-BASED PAYMENTS	3 Months Ended
SHARE-BASED PAYMENTS	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
SHARE-BASED PAYMENTS	SHARE-BASED PAYMENTS (a) Employee Stock Incentive Plans The 2021 Stock Incentive Plan (the “2021 Plan”) replaced the Amended and Restated 2009 Stock Incentive Plan on May 27, 2021. Share-based compensation expense for restricted stock units under the Company’s 2021 Plan was $16,860 and $5,299 for the three months ended March 31, 2022 and 2021, respectively. During the three months ended March 31, 2022, in connection with employee stock incentive plans, the Company granted 161,559 restricted stock units with a grant date fair value of $11,863 and 65,000 performance based restricted stock units with a grant date fair value of $2,329. During the three months ended March 31, 2021, in connection with employee stock incentive plans, the Company granted 48,714 restricted stock units with a grant date fair value of $2,234 and 1,100,000 performance based restricted stock units with a grant date fair value of $40,876. The restricted stock units generally vest over a period of one to five years based on continued service. Performance based restricted stock units generally vest based on both the employee’s continued service and the achievement of a set threshold of the Company’s common stock price, as defined in the grant, during the two to three-year period following the grant. In determining the fair value of restricted stock units on the grant date, the fair value is adjusted for (a) estimated forfeitures, (b) expected dividends based on historical patterns and the Company’s anticipated dividend payments over the expected holding period and (c) the risk-free interest rate based on U.S. Treasuries for a maturity matching the expected holding period. (b) Employee Stock Purchase Plan In connection with the Company’s Employee Stock Purchase Plan ("Purchase Plan"), share based compensation was $153 and $227 for the three months ended March 31, 2022 and 2021, respectively. As of March 31, 2022 and December 31, 2021, there were 450,717 shares reserved for issuance under the Purchase Plan. (c) Common Stock Since October 30, 2018, the Company’s Board of Directors has authorized annual share repurchase programs of up to $50,000 of its outstanding common shares. All share repurchases were effected on the open market at prevailing market prices or in privately negotiated transactions. During the three months ended March 31, 2022 and 2021, the Company did not repurchase shares of its common stock. The shares repurchased under the program are retired. On October 25, 2021, the share repurchase program was reauthorized by the Board of Directors for share repurchases up to $50,000 of its outstanding common shares and expires in October 2022. (d) Preferred Stock During the three months ended March 31, 2022 and 2021, the Company issued 20 and no depository shares of the Series A Preferred Stock, respectively. There were 2,834 and 2,814 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively. Total liquidation preference for the Series A Preferred Stock as of March 31, 2022 and December 31, 2021, was $70,854 and $70,362, respectively. Dividends on the Series A preferred paid during the three months ended March 31, 2022 and 2021, were $0.4296875 per depository share. During the three months ended March 31, 2022 and 2021, the Company issued 4 and no depository shares of the Series B Preferred Stock. There were 1,701 and 1,697 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively. Total liquidation preference for the Series B Preferred Stock as of March 31, 2022 and December 31, 2021, was $42,527 and $42,428, respectively. Dividends on the Series B preferred paid during the three months ended March 31, 2022 and 2021, were $0.4609375 per depository share.